Give yourself the gift of TIME.
Find the correct answer in seconds
100s of coding tools at your fingertips
Finish your work faster
Start enjoying your FindACode.com subscription today.
more...
CVX Vaccine Codes
CDC Immunization & Vaccine Code Set
The CDC's National Center of Immunization and Respiratory Diseases (NCIRD) developed and maintains the CVX (vaccine administered) code set. CVX codes for inactive vaccines allow transmission of historical immunization records. When a MVX (manufacturer) code is paired with a CVX (vaccine administered) code, the specific trade named vaccine may be indicated.
Use ICD-10-CM code Z23 Encounter for immunization to. CPT® codes are specific to the type of vaccine.
CVX codes by group
226 COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL Pending 212 COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL Active 225 COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL Active 301 COVID-19, mRNA, LNP-S, bivalent booster, PF, 10 mcg/0.2 mL dose Active 300 COVID-19, mRNA, LNP-S, bivalent booster, PF, 30 mcg/0.3 mL dose Active 229 COVID-19, mRNA, LNP-S, bivalent booster, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose Active 218 COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose Active 207 COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose Active 219 COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose Active 208 COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose Active 217 COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose Active 221 COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose Active 228 COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose Active 211 COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL Active 516 COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC) Non-US 510 COVID-19 IV Non-US Vaccine (BIBP, Sinopharm) Non-US 511 COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) Non-US 502 COVID-19 IV Non-US Vaccine (COVAXIN) Non-US 501 COVID-19 IV Non-US Vaccine (QAZCOVID-IN) Non-US 503 COVID-19 LAV Non-US Vaccine (COVIVAC) Non-US 500 COVID-19 Non-US Vaccine, Product Unknown Non-US 507 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences) Non-US 509 COVID-19 PS Non-US Vaccine (EpiVacCorona) Non-US 508 COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention) Non-US 210 COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL Non-US 506 COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology) Non-US 504 COVID-19 VVnr Non-US Vaccine (Sputnik Light) Non-US 505 COVID-19 VVnr Non-US Vaccine (Sputnik V) Non-US 514 SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D) Non-US 513 SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax) Non-US 517 SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax) Non-US 515 SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901) Non-US 512 SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz) Non-US 227 COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose Inactive 213 SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED Inactive
205 Influenza vaccine, quadrivalent, adjuvanted Active 135 Influenza, high dose seasonal Active 197 influenza, high-dose, quadrivalent Active 171 Influenza, injectable, MDCK, preservative free, quadrivalent Active 186 Influenza, injectable, MDCK, quadrivalent, preservative Active 158 influenza, injectable, quadrivalent Active 150 influenza, injectable, quadrivalent, preservative free Active 161 Influenza, injectable,quadrivalent, preservative free, pediatric Active 166 influenza, intradermal, quadrivalent, preservative free Active 149 influenza, live, intranasal, quadrivalent Active 155 influenza, recombinant, injectable, preservative free Active 185 influenza, recombinant, quadrivalent,injectable, preservative free Active 141 Influenza, seasonal, injectable Active 140 Influenza, seasonal, injectable, preservative free Active 144 influenza, seasonal, intradermal, preservative free Active 200 influenza, Southern Hemisphere, pediatric, preservative free Active 201 influenza, Southern Hemisphere, preservative free Active 202 influenza, Southern Hemisphere, quadrivalent, with preservative Active 168 influenza, trivalent, adjuvanted Active 151 influenza nasal, unspecified formulation Inactive 153 Influenza, injectable, MDCK, preservative free Inactive 111 influenza, live, intranasal Inactive 194 Influenza, Southern Hemisphere Inactive 15 influenza, split (incl. purified surface antigen) Inactive 88 influenza, unspecified formulation Inactive 16 influenza, whole Inactive
146 DTaP,IPV,Hib,HepB Active 110 DTaP-Hep B-IPV Active 104 Hep A-Hep B Active 08 Hep B, adolescent or pediatric Active 43 Hep B, adult Active 44 Hep B, dialysis Active 220 HepB recombinant, 3-antigen, Al(OH)3 Active 189 HepB-CpG Active 102 DTP-Hib-Hep B Non-US 193 Hep A-Hep B, pediatric/adolescent Non-US 132 DTaP-IPV-HIB-HEP B, historical Inactive 42 Hep B, adolescent/high risk infant Inactive 45 Hep B, unspecified formulation Inactive 51 Hib-Hep B Inactive
09 Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed Active 113 Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed Active 196 Td, adsorbed, preservative free, adult use, Lf unspecified Active 195 DT, IPV adsorbed Non-US 138 Td (adult) Inactive 139 Td(adult) unspecified formulation Inactive 35 tetanus toxoid, adsorbed Inactive
181 anthrax immune globulin Active 801 AS03 Adjuvant Active 27 botulinum antitoxin Active 29 CMVIG Active 12 diphtheria antitoxin Active 30 HBIG Active 86 IG Active 87 IGIV Active 157 Rho(D) -IG IM Active 156 Rho(D)-IG Active 34 RIG Active 71 RSV-IGIV Active 93 RSV-MAb Active 13 TIG Active 79 vaccinia immune globulin Active 36 VZIG Active 198 DTP-hepB-Hib Pentavalent Non-US Non-US 169 Hep A, live attenuated Non-US 191 meningococcal A polysaccharide (non-US) Non-US 192 meningococcal AC polysaccharide (non-US) Non-US 179 OPV ,monovalent, unspecified Non-US 178 OPV bivalent Non-US 190 Typhoid conjugate vaccine (TCV) Non-US 14 IG, unspecified formulation Inactive 167 meningococcal, unknown serogroups Inactive 998 no vaccine administered Inactive 182 OPV, Unspecified Inactive 69 parainfluenza-3 Inactive 11 pertussis Inactive 99 RESERVED - do not use Inactive 159 Rho(D) - Unspecified formulation Inactive 76 Staphylococcus bacterio lysate Inactive 180 tetanus immune globulin Inactive 142 tetanus toxoid, not adsorbed Inactive 112 tetanus toxoid, unspecified formulation Inactive 98 TST, unspecified formulation Inactive 95 TST-OT tine test Inactive 96 TST-PPD intradermal Inactive 97 TST-PPD tine test Inactive 78 tularemia vaccine Inactive 131 typhus, historical Inactive 999 unknown Inactive 57 hantavirus Never Active 154 Hep A, IG Never Active 58 Hep C Never Active 59 Hep E Never Active 60 herpes simplex 2 Never Active 61 HIV Never Active 63 Junin virus Never Active 64 leishmaniasis Never Active 65 leprosy Never Active 67 malaria Never Active 68 melanoma Never Active 70 Q fever Never Active 72 rheumatic fever Never Active 73 Rift Valley fever Never Active 145 RSV-MAb (new) Never Active 117 VZIG (IND) Never Active
CVX codes by manufacturer current/active Parent Company of MedImmune
manufacturer of national stockpile smallpox vaccine Jynneos
Non-US COVID-19 Vaccine Manufacturer - WHO Authorized (COVAXIN)
Formerly Emergent BioDefense Operations Lansing and Michigan Biologic Products Institute
Emergent Biosolutions acquired PaxVax 8/2021, US Vaccines starting to label under Emergent Travel Health Inc.
includes SmithKline Beecham and Glaxo Wellcome
801 AS03 Adjuvant Inactive AS03 adjuvant 20 DTaP Active INFANRIX 110 DTaP-Hep B-IPV Active PEDIARIX 130 DTaP-IPV Active KINRIX 52 Hep A, adult Active HAVRIX-ADULT 83 Hep A, ped/adol, 2 dose Active HAVRIX-PEDS 104 Hep A-Hep B Active TWINRIX 08 Hep B, adolescent or pediatric Active ENGERIX B-PEDS 43 Hep B, adult Active ENGERIX-B-ADULT 48 Hib (PRP-T) Active HIBERIX 118 HPV, bivalent Inactive CERVARIX 160 Influenza A monovalent (H5N1), ADJUVANTED-2013 Inactive Influenza A monovalent (H5N1), ADJUVANTED-2013 150 influenza, injectable, quadrivalent, preservative free Active Fluarix, quadrivalent, preservative free 140 Influenza, seasonal, injectable, preservative free Active FLUARIX 163 meningococcal B, OMV Active Bexsero 148 Meningococcal C/Y-HIB PRP Inactive MENHIBRIX 136 Meningococcal MCV4O Active Menveo 03 MMR Active Priorix 176 Rabies - IM fibroblast culture Active RABAVERT 119 rotavirus, monovalent Active ROTARIX 115 Tdap Active BOOSTRIX 187 zoster recombinant Active SHINGRIX
Grifols is a labeler and not a manufacturer.
Part of GlaxoSmithKline
160 Influenza A monovalent (H5N1), ADJUVANTED-2013 Active Influenza A (H5N1) -2013 158 influenza, injectable, quadrivalent Active Flulaval quadrivalent 150 influenza, injectable, quadrivalent, preservative free Active Flulaval, quadrivalent, preservative free 141 Influenza, seasonal, injectable Active FLULAVAL 140 Influenza, seasonal, injectable, preservative free Active Flulaval, preservative free
Division of Johnson and Johnson, manufacturer of Covid-19 vaccine
formerly Massachusetts Public Health Biologic Laboratories
Non-US COVID-19 vaccine manufacturer Cofivenz vaccine recognized by ACIP
Subsidiary of AstraZeneca
19 BCG Active TICE BCG 204 Ebola Zaire vaccine, live, recombinant, 1mL dose Active ERVEBO (Ebola Zaire Vaccine, Live) 52 Hep A, adult Active VAQTA-ADULT 83 Hep A, ped/adol, 2 dose Active VAQTA-PEDS 08 Hep B, adolescent or pediatric Active RECOMBIVAX-PEDS 43 Hep B, adult Active RECOMBIVAX-ADULT 44 Hep B, dialysis Active RECOMBIVAX-DIALYSIS 49 Hib (PRP-OMP) Active PEDVAXHIB 51 Hib-Hep B Inactive COMVAX 62 HPV, quadrivalent Inactive GARDASIL 165 HPV9 Active Gardasil 9 05 measles Inactive ATTENUVAX 03 MMR Active M-M-R II 94 MMRV Active PROQUAD 215 Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF Active VAXNEUVANCE 33 pneumococcal polysaccharide PPV23 Active PNEUMOVAX 23 116 rotavirus, pentavalent Active ROTATEQ 06 rubella Inactive MERUVAX II 21 varicella Active VARIVAX 121 zoster live Active ZOSTAVAX
New vaccine manufacturer effective 11/1/2020
229 COVID-19, mRNA, LNP-S, bivalent booster, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose Active Moderna COVID-19 Vaccine (non-US Spikevax) 207 COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose Active Moderna COVID-19 Vaccine (non-US Spikevax) 207 COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose Active SPIKEVAX 221 COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose Active Moderna COVID-19 Vaccine (non-US Spikevax) 228 COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose Active Moderna COVID-19 Vaccine (non-US Spikevax) 227 COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose Active Moderna COVID-19 Vaccine (non-US Spikevax)
US Based - Joint manufacturing partnership, initial vaccine Vaxelis 10/2020
COVID-19 vaccine in co-development with BioNTech. Pfizer includes Wyeth-Lederle Vaccines and Pediatrics, Wyeth Laboratories, Lederle Laboratories, and Praxis Biologics
301 COVID-19, mRNA, LNP-S, bivalent booster, PF, 10 mcg/0.2 mL dose Active Pfizer-BioNTech COVID-19 Vaccine (EUA labeled) COMIRNATY (BLA labeled) 300 COVID-19, mRNA, LNP-S, bivalent booster, PF, 30 mcg/0.3 mL dose Active Pfizer-BioNTech COVID-19 Vaccine (EUA labeled) COMIRNATY (BLA labeled) 218 COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose Active Pfizer-BioNTech COVID-19 Vaccine (EUA labeled) COMIRNATY (BLA labeled) 219 COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose Active Pfizer-BioNTech COVID-19 Vaccine (EUA labeled) COMIRNATY (BLA labeled) 208 COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose Active COMIRNATY 208 COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose Active Pfizer-BioNTech COVID-19 Vaccine (EUA labeled) COMIRNATY (BLA labeled) 217 COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose Active COMIRNATY 217 COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose Active Pfizer-BioNTech COVID-19 Vaccine (EUA labeled) COMIRNATY (BLA labeled) 162 meningococcal B, recombinant Active Trumenba 133 Pneumococcal conjugate PCV 13 Active PREVNAR 13 216 Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF Active PREVNAR 20 223 Tick-borne encephalitis, inactivated, PF, 0.25mL Active TICOVAC 224 Tick-borne encephalitis, inactivated, PF, 0.5mL Active TICOVAC
Formerly Aventis Pasteur, Pasteur Merieux Connaught; includes Connaught Laboratories and Pasteur Merieux. Acquired ACAMBIS; Acquired Protein Sciences (8/28/2017)
226 COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL Active Sanofi COVID-19 225 COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL Active Sanofi COVID-19 56 dengue fever Active DENGVAXIA 28 DT (pediatric) Active DT(GENERIC) 20 DTaP Inactive TRIPEDIA 106 DTaP, 5 pertussis antigens Active DAPTACEL 50 DTaP-Hib Inactive TRIHIBIT 120 DTaP-Hib-IPV Active PENTACEL 130 DTaP-IPV Active Quadracel 48 Hib (PRP-T) Active ACTHIB 135 Influenza, high dose seasonal Active FLUZONE-HIGH DOSE 197 influenza, high-dose, quadrivalent Active FLUZONE High-Dose Quadrivalent 158 influenza, injectable, quadrivalent Active Fluzone, Quadrivalent 150 influenza, injectable, quadrivalent, preservative free Active Fluzone, quadrivalent, preservative free 161 Influenza, injectable,quadrivalent, preservative free, pediatric Active Fluzone Quadrivalent, pediatric 166 influenza, intradermal, quadrivalent, preservative free Active Fluzone Quad Intradermal 185 influenza, recombinant, quadrivalent,injectable, preservative free Active Flublok quadrivalent 141 Influenza, seasonal, injectable Active FLUZONE 140 Influenza, seasonal, injectable, preservative free Active FLUZONE-PRESERVATIVE FREE 144 influenza, seasonal, intradermal, preservative free Active Fluzone, intradermal 200 influenza, Southern Hemisphere, pediatric, preservative free Active FLUZONE Quadrivalent Southern Hemisphere, Pediatric 201 influenza, Southern Hemisphere, preservative free Active FLUZONE Quadrivalent Southern Hemisphere 202 influenza, Southern Hemisphere, quadrivalent, with preservative Active FLUZONE Quadrivalent Southern Hemisphere 10 IPV Active IPOL 114 meningococcal MCV4P Active MENACTRA 32 meningococcal MPSV4 Inactive MENOMUNE 203 meningococcal polysaccharide (groups A, C, Y, W-135) TT conjugate Active MenQuadfi 127 Novel influenza-H1N1-09 Inactive Novel influenza-H1N1-09 126 Novel influenza-H1N1-09, preservative-free Inactive Novel influenza-H1N1-09, preservative-free 175 Rabies - IM Diploid cell culture Active IMOVAX 40 rabies, intradermal injection Inactive IMOVAX ID 18 rabies, intramuscular injection Inactive Imovax 113 Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed Inactive DECAVAC 113 Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed Active Tenivac 115 Tdap Active ADACEL 35 tetanus toxoid, adsorbed Inactive TETANUS TOXOID (GENERIC) 101 typhoid, ViCPs Active TYPHIM VI 37 yellow fever Active YF-VAX 183 Yellow fever vaccine - alt Active Stamaril
Seqirus acquired the flu vaccines from Novartis. It also includes the CSL vaccines.
205 Influenza vaccine, quadrivalent, adjuvanted Active FLUAD Quadrivalent 171 Influenza, injectable, MDCK, preservative free, quadrivalent Active flucelvax, quadrivalent, preservative free 186 Influenza, injectable, MDCK, quadrivalent, preservative Active Flucelvax, quadrivalent, with preservative 158 influenza, injectable, quadrivalent Active Afluria, quadrivalent 150 influenza, injectable, quadrivalent, preservative free Active Afluria quadrivalent preservative free 161 Influenza, injectable,quadrivalent, preservative free, pediatric Active Afluria quadrivalent, preservative free, pediatric 141 Influenza, seasonal, injectable Active Afluria 141 Influenza, seasonal, injectable Active Fluvirin 140 Influenza, seasonal, injectable, preservative free Active Afluria, preservative free 140 Influenza, seasonal, injectable, preservative free Active Fluvirin preservative free 168 influenza, trivalent, adjuvanted Active Fluad
Non-US COVID-19 Vaccine Manufacturer - WHO Authorized
Non-US COVID-19 Vaccine Manufacturer - WHO Authorized (Sinovac, CoronaVac)
BARR Laboratories merged with TEVA in 2007. The MVX for Barr was retired in 2011, TEVA continues to produce the former BARR vaccines
Distributes through Intercell in the US
New Vaccine Manufacturer added 1/2022
acquired by Pfizer 10/15/2009
Non-US 173 cholera, BivWC Non-US n/a 172 cholera, WC-rBS Non-US n/a 516 COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC) Non-US n/a 501 COVID-19 IV Non-US Vaccine (QAZCOVID-IN) Non-US n/a 503 COVID-19 LAV Non-US Vaccine (COVIVAC) Non-US n/a 500 COVID-19 Non-US Vaccine, Product Unknown Non-US n/a 507 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences) Non-US n/a 509 COVID-19 PS Non-US Vaccine (EpiVacCorona) Non-US n/a 508 COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention) Non-US n/a 506 COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology) Non-US n/a 504 COVID-19 VVnr Non-US Vaccine (Sputnik Light) Non-US n/a 505 COVID-19 VVnr Non-US Vaccine (Sputnik V) Non-US n/a 195 DT, IPV adsorbed Non-US n/a 170 DTAP/IPV/HIB - non-US Non-US n/a 198 DTP-hepB-Hib Pentavalent Non-US Non-US n/a 102 DTP-Hib-Hep B Non-US n/a 169 Hep A, live attenuated Non-US n/a 193 Hep A-Hep B, pediatric/adolescent Non-US n/a 191 meningococcal A polysaccharide (non-US) Non-US n/a 192 meningococcal AC polysaccharide (non-US) Non-US n/a 179 OPV ,monovalent, unspecified Non-US n/a 178 OPV bivalent Non-US n/a 177 PCV10 Non-US n/a 514 SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D) Non-US n/a 513 SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax) Non-US n/a 517 SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax) Non-US n/a 515 SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901) Non-US n/a 77 Tick-borne encephalitis vaccine (non-US) Non-US n/a 190 Typhoid conjugate vaccine (TCV) Non-US n/a
Inactive acquired by sanofi in sept 2008
Subsidiary of Teva Pharmaceuticals
acquired Berna, now a J & J company
Novartis has sold its flu vaccines to Seqirus and other vaccines to GlaxoSmithKline. While Novartis vaccines may still be in circulation, its status is set to not active.
153 Influenza, injectable, MDCK, preservative free Inactive Flucelvax 141 Influenza, seasonal, injectable Active FLUVIRIN 140 Influenza, seasonal, injectable, preservative free Inactive AGRIFLU 140 Influenza, seasonal, injectable, preservative free Active FLUVIRIN-PRESERVATIVE FREE 168 influenza, trivalent, adjuvanted Active Fluad 163 meningococcal B, OMV Active Bexsero 136 Meningococcal MCV4O Active MENVEO 127 Novel influenza-H1N1-09 Inactive Novel influenza-H1N1-09 126 Novel influenza-H1N1-09, preservative-free Inactive Novel influenza-H1N1-09, preservative-free 176 Rabies - IM fibroblast culture Inactive RABAVERT
Acquired by Sanofi Pasteur (08/28/2017)
54 adenovirus, type 4 Inactive n/a 55 adenovirus, type 7 Inactive n/a 82 adenovirus, unspecified formulation Inactive n/a 19 BCG Inactive MYCOBAX 26 cholera, unspecified formulation Inactive n/a 20 DTaP Inactive ACEL-IMUNE 20 DTaP Inactive CERTIVA 107 DTaP, unspecified formulation Inactive n/a 132 DTaP-IPV-HIB-HEP B, historical Inactive n/a 01 DTP Inactive n/a 22 DTP-Hib Inactive TETRAMUNE 214 Ebola, unspecified Inactive n/a 84 Hep A, ped/adol, 3 dose Inactive n/a 31 Hep A, pediatric, unspecified formulation Inactive n/a 85 Hep A, unspecified formulation Inactive n/a 42 Hep B, adolescent/high risk infant Inactive n/a 45 Hep B, unspecified formulation Inactive n/a 47 Hib (HbOC) Inactive HIBTITER 46 Hib (PRP-D) Inactive PROHIBIT 48 Hib (PRP-T) Inactive OMNIHIB 17 Hib, unspecified formulation Inactive n/a 137 HPV, unspecified formulation Inactive n/a 14 IG, unspecified formulation Inactive n/a 151 influenza nasal, unspecified formulation Inactive n/a 123 influenza, H5N1-1203 Inactive n/a 194 Influenza, Southern Hemisphere Inactive n/a 15 influenza, split (incl. purified surface antigen) Inactive n/a 88 influenza, unspecified formulation Inactive n/a 16 influenza, whole Inactive n/a 129 Japanese Encephalitis, unspecified formulation Inactive n/a 66 Lyme disease Inactive n/a 04 M/R Inactive n/a 108 meningococcal ACWY, unspecified formulation Inactive n/a 164 meningococcal B, unspecified Inactive n/a 103 meningococcal C conjugate Inactive n/a 147 meningococcal MCV4, unspecified formulation Inactive n/a 167 meningococcal, unknown serogroups Inactive n/a 07 mumps Inactive MUMPSVAX 998 no vaccine administered Inactive n/a 128 Novel Influenza-H1N1-09, all formulations Inactive n/a 02 OPV Inactive ORIMUNE 182 OPV, Unspecified Inactive n/a 69 parainfluenza-3 Inactive n/a 11 pertussis Inactive n/a 23 plague Inactive n/a 152 Pneumococcal Conjugate, unspecified formulation Inactive n/a 109 pneumococcal, unspecified formulation Inactive n/a 89 polio, unspecified formulation Inactive n/a 90 rabies, unspecified formulation Inactive n/a 99 RESERVED - do not use Inactive n/a 159 Rho(D) - Unspecified formulation Inactive n/a 74 rotavirus, tetravalent Inactive n/a 122 rotavirus, unspecified formulation Inactive n/a 38 rubella/mumps Inactive BIAVAX II 213 SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED Inactive n/a 76 Staphylococcus bacterio lysate Inactive n/a 138 Td (adult) Inactive n/a 139 Td(adult) unspecified formulation Inactive n/a 180 tetanus immune globulin Inactive n/a 142 tetanus toxoid, not adsorbed Inactive n/a 112 tetanus toxoid, unspecified formulation Inactive n/a 222 Tick-borne encephalitis, unspecified Inactive n/a 98 TST, unspecified formulation Inactive n/a 95 TST-OT tine test Inactive n/a 96 TST-PPD intradermal Inactive n/a 97 TST-PPD tine test Inactive n/a 78 tularemia vaccine Inactive n/a 41 typhoid, parenteral Inactive n/a 53 typhoid, parenteral, AKD (U.S. military) Inactive TYPHOID-AKD 91 typhoid, unspecified formulation Inactive n/a 131 typhus, historical Inactive n/a 999 unknown Inactive n/a 75 vaccinia (smallpox) Inactive DRYVAX 105 vaccinia (smallpox) diluted Inactive n/a 81 VEE, inactivated Inactive n/a 80 VEE, live Inactive n/a 92 VEE, unspecified formulation Inactive n/a 184 Yellow fever, unspecified formulation Inactive n/a 188 zoster, unspecified formulation Inactive n/a
Never Active
About CVX Codes
In 1999, the CDC published an implementation guide for messaging immunization histories. Two value sets were defined that allowed specification of the vaccine used at the vaccine administration level. The CVX code is a numeric string, which identifies the type of vaccine
product used. The MVX code is an alphabetic string that identifies the manufacturer of that vaccine. Taken together, the immunization can be resolved to a trade name (the proprietary name of the product).
For example, a CVX code of 43 represents Hepatitis B, adult formulation. There are 2 manufacturers of this vaccine, GlaxoSmithKline (MVX = SKB) and Merck (MVX = MSD). An immunization using Recombivax, a Hepatitis B vaccine manufactured by Merck, would have a CVX of 43 and an MVX of MSD.
When these codes were developed, they were designed to accommodate reporting of vaccine histories when the manufacturer and trade name are not known. This is because a client often had a shot card listing the vaccinations received, but with only a date and vaccine group listed. If the manufacturer and formulation were not known, then the Hepatitis B vaccine administered would be coded with a CVX of 45 (Hepatitis B, not otherwise specified).
Other codes exist that are associated with the coding of a vaccine. These include: RxNorm, NDC , and CPT® . RxNorm, a standardized nomenclature for clinical drugs and drug delivery devices, is produced by the National Library of Medicine (NLM). In RxNorm, the name of a clinical drug combines its ingredients, strengths, and/or form.
Typically, there are a number of factors that determine which vaccine will have the same or a different CVX code:
the formulation
the concentration
the manufacturing process (egg culture vs. cell culture)
the route of administration
MVX Codes - Manufacturers of Vaccines
The MVX is an alphabetic string, which represents the manufacturer of a vaccine. When MVX code is paired with a CVX (vaccine administered) code, the specific trade named vaccine may be indicated. The MVX code reflects the manufacturer of the specific instance of the vaccine. For example, Pfizer (MVX = PFR) acquired Wyeth (MVX = WAL). Prevnar is a vaccine that was manufactured by Wyeth. Immunizations of Prevnar that were manufactured by Wyeth continue to use the MVX of WAL. Prevnar that is now manufactured by Pfizer will have an MVX of PFR. Existing records will not be changed.
source: https://www.cdc.gov/vaccines/programs/iis/downloads/business-rules.pdf
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com